“They (FDA) will hold Leronlimab back because they can, while claiming to follow the rules. It will be this way until a Trial with a passing P-Value is completed.”
The problem isn’t the FDA and their rules, it’s NP and the poor people he has surrounded himself with, including Amarex.
News 
Market Data 
Discover 
